Skip to content
Brasil Peru Mexico

 

  • CROI 2025 – Enhancing PrEP Coverage With CAB-LA in Young Key Populations (oral presentation)

  • CROI 2025 – Factors Influencing Doxy-PEP Awareness Among Sexual/Gender Minorities: A Web-Based Survey in Brazil (poster)

  • CROI 2025 – Depression and Suicide Risk Among Sexual and Gender Minorities: Insights From the ImPrEP CAB Brasil (poster)

  • CROI 2025 – PrEP Use Trajectories and HIV Incidence Among PrEP Users in Brazil: Findings From the ImPrEP Study (poster)

Imprep
Rio de Janeiro: Fundação Oswaldo Cruz – Fiocruz Av. Brasil, 4365 - Rio de Janeiro
9090 (21) 2260-6700 e (21) 3865-9659
imprep.bra@gmail.com
  • Home
  • What is PrEP?
  • IMPREP project
  • Sites that provide PrEP
  • Studies and Research
    • Presentations at Conferences
    • Published Articles

Category: Studies and Researches

Studies and Researches

Baseline variables associated with subsequent HIV seroconversion among gay, bisexual and other men who have sex with men and transgender women: a prospective, multicenter PrEP demonstration study (ImPrEP)

Article by ImPrEP published at The Lancet Regional Health - Americas, in 2025, June, https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00108-5/fulltext

19 de May de 202516 de June de 2025
Studies and Researches

Factors Associated with Low/Moderate Perceived Risk for HIV Acquisition Among Gay, Bisexual, and Other Men Who Have Sex with Men Eligible to Use Pre‑exposure Prophylaxis from Brazil, Mexico, and Peru

Article by ImPrEP published at Archives of Sexual Behavior,in 2025, January, https://rdcu.be/d7JyS

29 de January de 2025
Studies and Researches

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Article by ImPrEP published at JMIR Publications, in 2024, October https://publichealth.jmir.org/2024/1/e60961

31 de October de 202431 de October de 2024
Studies and Researches

Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study

Article by ImPrEP published at The Lancet HIV in 2024, September https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00211-X/fulltext

5 de September de 20245 de September de 2024
Studies and Researches

Awareness of U = U among Sexual and Gender Minorities in Brazil, Mexico, and Peru: Differences According to Self-reported HIV Status

Article by ImPrEP published at AIDS and Behavior in 2024, April https://link.springer.com/article/10.1007/s10461-024-04336-9

18 de July de 2024
Studies and Researches

Preferences for pre-exposure prophylaxis (PrEP) among sexual and gender minorities: a discrete choice experiment in Brazil

Article by ImPrEP published at The Lancet Regional Health – Americas in 2023, March https://doi.org/10.1016/j.lana.2023.100432

18 de July de 2024
Studies and Researches

Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study

Article by ImPrEP published at The Lancet Regional Health – Americas in 2023, December https://doi.org/10.1016/j.lana.2023.100642

18 de July de 2024
Studies and Researches

Costs of implementing long-acting injectable cabotegravir as HIV prophylaxis in Brazil

Article by ImPrEP published at Physis in2023, September https://doi.org/10.1590/S0103-7331202333021

18 de July de 2024
Studies and Researches

Preferences for PrEP modalities among gay, bisexual, and other men who have sex with men from Brazil, Mexico, and Peru: a cross-sectional study

Article by ImPrEP published at Therapeutic Advances in Infectious Disease in 2023, February https://doi.org/10.1177/20499361231153548

18 de July de 2024
Studies and Researches

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Article by ImPrEP published at JMIR Public Health and Surveillance in 2023, April http://dx.doi.org/10.2196/44961

18 de July de 2024

Posts navigation

Older posts

Partners

UnitAid INI - Instituto Nacional de Infectologia Evandro Chagas Fundação Oswaldo Cruz Ministério da Saúde do Brasil UnitAid Universidad Peruana Cayetano Heredia Instituto Nacional de Salud Pública CONDESA Instituto Nacional de Infectologia Evandro Chagas Fundação Oswaldo Cruz Ministério da Saúde - Brasil
Theme of Rigorous Themes